First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) Trading 0.6% Higher – Should You Buy?

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT)’s stock price traded up 0.6% on Thursday . The company traded as high as GBX 1,591.60 ($21.29) and last traded at GBX 1,591.60 ($21.29). 431 shares were traded during trading, a decline of 76% from the average session volume of 1,764 shares. The stock had previously closed at GBX 1,582 ($21.16).

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Trading Up 0.6 %

The company has a quick ratio of 9.27, a current ratio of 9.42 and a debt-to-equity ratio of 0.04. The firm’s 50 day moving average is GBX 1,572.08 and its two-hundred day moving average is GBX 1,501.74. The stock has a market cap of £4.70 billion and a price-to-earnings ratio of -1,446.91.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile

Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.